These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 23536562)

  • 1. Genetic susceptibility to triple-negative breast cancer.
    Stevens KN; Vachon CM; Couch FJ
    Cancer Res; 2013 Apr; 73(7):2025-30. PubMed ID: 23536562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women.
    Comen E; Davids M; Kirchhoff T; Hudis C; Offit K; Robson M
    Breast Cancer Res Treat; 2011 Aug; 129(1):185-90. PubMed ID: 21394499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common breast cancer susceptibility loci are associated with triple-negative breast cancer.
    Stevens KN; Vachon CM; Lee AM; Slager S; Lesnick T; Olswold C; Fasching PA; Miron P; Eccles D; Carpenter JE; Godwin AK; Ambrosone C; Winqvist R; Brauch H; ; Schmidt MK; Cox A; Cross SS; Sawyer E; Hartmann A; Beckmann MW; Schulz-Wendtland R; Ekici AB; Tapper WJ; Gerty SM; Durcan L; Graham N; Hein R; Nickels S; Flesch-Janys D; Heinz J; Sinn HP; Konstantopoulou I; Fostira F; Pectasides D; Dimopoulos AM; Fountzilas G; Clarke CL; Balleine R; Olson JE; Fredericksen Z; Diasio RB; Pathak H; Ross E; Weaver J; Rüdiger T; Försti A; Dünnebier T; Ademuyiwa F; Kulkarni S; Pylkäs K; Jukkola-Vuorinen A; Ko YD; Van Limbergen E; Janssen H; Peto J; Fletcher O; Giles GG; Baglietto L; Verhoef S; Tomlinson I; Kosma VM; Beesley J; Greco D; Blomqvist C; Irwanto A; Liu J; Blows FM; Dawson SJ; Margolin S; Mannermaa A; Martin NG; Montgomery GW; Lambrechts D; dos Santos Silva I; Severi G; Hamann U; Pharoah P; Easton DF; Chang-Claude J; Yannoukakos D; Nevanlinna H; Wang X; Couch FJ
    Cancer Res; 2011 Oct; 71(19):6240-9. PubMed ID: 21844186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype.
    Wiese DA; Thaiwong T; Yuzbasiyan-Gurkan V; Kiupel M
    BMC Cancer; 2013 Sep; 13():403. PubMed ID: 24004841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
    Mulligan AM; Couch FJ; Barrowdale D; Domchek SM; Eccles D; Nevanlinna H; Ramus SJ; Robson M; Sherman M; Spurdle AB; Wappenschmidt B; Lee A; McGuffog L; Healey S; Sinilnikova OM; Janavicius R; Hansen Tv; Nielsen FC; Ejlertsen B; Osorio A; Muñoz-Repeto I; Durán M; Godino J; Pertesi M; Benítez J; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Cattaneo E; Bonanni B; Viel A; Pasini B; Papi L; Ottini L; Savarese A; Bernard L; Radice P; Hamann U; Verheus M; Meijers-Heijboer HE; Wijnen J; Gómez García EB; Nelen MR; Kets CM; Seynaeve C; Tilanus-Linthorst MM; van der Luijt RB; van Os T; Rookus M; Frost D; Jones JL; Evans DG; Lalloo F; Eeles R; Izatt L; Adlard J; Davidson R; Cook J; Donaldson A; Dorkins H; Gregory H; Eason J; Houghton C; Barwell J; Side LE; McCann E; Murray A; Peock S; Godwin AK; Schmutzler RK; Rhiem K; Engel C; Meindl A; Ruehl I; Arnold N; Niederacher D; Sutter C; Deissler H; Gadzicki D; Kast K; Preisler-Adams S; Varon-Mateeva R; Schoenbuchner I; Fiebig B; Heinritz W; Schäfer D; Gevensleben H; Caux-Moncoutier V; Fassy-Colcombet M; Cornelis F; Mazoyer S; Léoné M; Boutry-Kryza N; Hardouin A; Berthet P; Muller D; Fricker JP; Mortemousque I; Pujol P; Coupier I; Lebrun M; Kientz C; Longy M; Sevenet N; Stoppa-Lyonnet D; Isaacs C; Caldes T; de la Hoya M; Heikkinen T; Aittomäki K; Blanco I; Lazaro C; Barkardottir RB; Soucy P; Dumont M; Simard J; Montagna M; Tognazzo S; D'Andrea E; Fox S; Yan M; Rebbeck T; Olopade O; Weitzel JN; Lynch HT; Ganz PA; Tomlinson GE; Wang X; Fredericksen Z; Pankratz VS; Lindor NM; Szabo C; Offit K; Sakr R; Gaudet M; Bhatia J; Kauff N; Singer CF; Tea MK; Gschwantler-Kaulich D; Fink-Retter A; Mai PL; Greene MH; Imyanitov E; O'Malley FP; Ozcelik H; Glendon G; Toland AE; Gerdes AM; Thomassen M; Kruse TA; Jensen UB; Skytte AB; Caligo MA; Soller M; Henriksson K; Wachenfeldt vA; Arver B; Stenmark-Askmalm M; Karlsson P; Ding YC; Neuhausen SL; Beattie M; Pharoah PD; Moysich KB; Nathanson KL; Karlan BY; Gross J; John EM; Daly MB; Buys SM; Southey MC; Hopper JL; Terry MB; Chung W; Miron AF; Goldgar D; Chenevix-Trench G; Easton DF; Andrulis IL; Antoniou AC; ; ; ; ; ; ; ;
    Breast Cancer Res; 2011; 13(6):R110. PubMed ID: 22053997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA2 mutations and triple-negative breast cancer.
    Meyer P; Landgraf K; Högel B; Eiermann W; Ataseven B
    PLoS One; 2012; 7(5):e38361. PubMed ID: 22666503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
    Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
    BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer.
    Newman LA; Reis-Filho JS; Morrow M; Carey LA; King TA
    Ann Surg Oncol; 2015 Mar; 22(3):874-82. PubMed ID: 25527230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?
    Albergaria A; Ricardo S; Milanezi F; Carneiro V; Amendoeira I; Vieira D; Cameselle-Teijeiro J; Schmitt F
    BMC Cancer; 2011 Jul; 11():299. PubMed ID: 21762477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer.
    Rummel S; Varner E; Shriver CD; Ellsworth RE
    Breast Cancer Res Treat; 2013 Jan; 137(1):119-25. PubMed ID: 23192404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers.
    Zugazagoitia J; Pérez-Segura P; Manzano A; Blanco I; Vega A; Custodio A; Teulé A; Fachal L; Martínez B; González-Sarmiento R; Cruz-Hernández JJ; Chirivella I; Garcés V; Garre P; Romero A; Caldés T; Díaz-Rubio E; de la Hoya M
    Breast Cancer Res Treat; 2014 Nov; 148(2):415-21. PubMed ID: 25342642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple-negative breast cancer: epidemiological considerations and recommendations.
    Boyle P
    Ann Oncol; 2012 Aug; 23 Suppl 6():vi7-12. PubMed ID: 23012306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer.
    Phuah SY; Looi LM; Hassan N; Rhodes A; Dean S; Taib NA; Yip CH; Teo SH
    Breast Cancer Res; 2012 Nov; 14(6):R142. PubMed ID: 23116406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease.
    Kaur P; Nagaraja GM; Zheng H; Gizachew D; Galukande M; Krishnan S; Asea A
    BMC Cancer; 2012 Mar; 12():120. PubMed ID: 22452810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 19p13.1 is a triple-negative-specific breast cancer susceptibility locus.
    Stevens KN; Fredericksen Z; Vachon CM; Wang X; Margolin S; Lindblom A; Nevanlinna H; Greco D; Aittomäki K; Blomqvist C; Chang-Claude J; Vrieling A; Flesch-Janys D; Sinn HP; Wang-Gohrke S; Nickels S; Brauch H; ; Ko YD; Fischer HP; Schmutzler RK; Meindl A; Bartram CR; Schott S; Engel C; Godwin AK; Weaver J; Pathak HB; Sharma P; Brenner H; Müller H; Arndt V; Stegmaier C; Miron P; Yannoukakos D; Stavropoulou A; Fountzilas G; Gogas HJ; Swann R; Dwek M; Perkins A; Milne RL; Benítez J; Zamora MP; Pérez JI; Bojesen SE; Nielsen SF; Nordestgaard BG; Flyger H; Guénel P; Truong T; Menegaux F; Cordina-Duverger E; Burwinkel B; Marmé F; Schneeweiss A; Sohn C; Sawyer E; Tomlinson I; Kerin MJ; Peto J; Johnson N; Fletcher O; Dos Santos Silva I; Fasching PA; Beckmann MW; Hartmann A; Ekici AB; Lophatananon A; Muir K; Puttawibul P; Wiangnon S; Schmidt MK; Broeks A; Braaf LM; Rosenberg EH; Hopper JL; Apicella C; Park DJ; Southey MC; Swerdlow AJ; Ashworth A; Orr N; Schoemaker MJ; Anton-Culver H; Ziogas A; Bernstein L; Dur CC; Shen CY; Yu JC; Hsu HM; Hsiung CN; Hamann U; Dünnebier T; Rüdiger T; Ulmer HU; Pharoah PP; Dunning AM; Humphreys MK; Wang Q; Cox A; Cross SS; Reed MW; Hall P; Czene K; Ambrosone CB; Ademuyiwa F; Hwang H; Eccles DM; Garcia-Closas M; Figueroa JD; Sherman ME; Lissowska J; Devilee P; Seynaeve C; Tollenaar RA; Hooning MJ; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; John EM; Miron A; Alnæs GG; Kristensen V; Børresen-Dale AL; Giles GG; Baglietto L; McLean CA; Severi G; Kosel ML; Pankratz VS; Slager S; Olson JE; Radice P; Peterlongo P; Manoukian S; Barile M; Lambrechts D; Hatse S; Dieudonne AS; Christiaens MR; Chenevix-Trench G; ; ; Beesley J; Chen X; Mannermaa A; Kosma VM; Hartikainen JM; Soini Y; Easton DF; Couch FJ
    Cancer Res; 2012 Apr; 72(7):1795-803. PubMed ID: 22331459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer.
    Pern F; Bogdanova N; Schürmann P; Lin M; Ay A; Länger F; Hillemanns P; Christiansen H; Park-Simon TW; Dörk T
    PLoS One; 2012; 7(10):e47993. PubMed ID: 23110154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple-negative breast cancer: current state of the art.
    Rastelli F; Biancanelli S; Falzetta A; Martignetti A; Casi C; Bascioni R; Giustini L; Crispino S
    Tumori; 2010; 96(6):875-88. PubMed ID: 21388048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Triple-negative breast carcinoma--rewiev of current literature].
    Rubovszky G; Udvarhelyi N; Horváth Z; Láng I; Kásler M
    Magy Onkol; 2010 Dec; 54(4):325-35. PubMed ID: 21163763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of triple negative breast cancer (TNBC): current options and future perspectives.
    De Laurentiis M; Cianniello D; Caputo R; Stanzione B; Arpino G; Cinieri S; Lorusso V; De Placido S
    Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S80-6. PubMed ID: 21129616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.
    Aloraifi F; Alshehhi M; McDevitt T; Cody N; Meany M; O'Doherty A; Quinn CM; Green AJ; Bracken A; Geraghty JG
    Eur J Surg Oncol; 2015 May; 41(5):641-6. PubMed ID: 25736863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.